RxDoctor Payments Data

Tait Shanafelt, MD

Hematology · Stanford, CANPI 1295712677

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology clinicians in CA, where the typical reported total is $4,615.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$441,418,573in research payments, 2019–2025

Across 185 payments — averaging $2,386,046 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$300M
  • AbbVie$136.8M
  • Genentech, Inc.$4.6M

How this compares

$0 in reported general payments places this provider in the 0th percentile of 178 hematology providers in California.

See all hematology providers in California

Medicare billing

Part B allowed, 2024
$29,165
Medicare patients
85
Services billed
154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →